Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market ...Middle East

HOUSTON, Dec. 20, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. (NASDAQ: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced that it has entered into a securities...

Hence then, the article about moleculin announces pricing of 4 5 million registered direct offering and concurrent private placement priced at the market was published today ( Thursday 21/12/2023 - 05:21 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market )

Also on site :

• Infighting, court battles could put long-hyped air taxi breakthrough in jeopardy
• ‘Deadpool & Wolverine’ Stars Ryan Reynolds & Hugh Jackman Reunite For Disney+ Sailing Docuseries
• This Trendy NoMad Hotel Is the Ultimate 2026 World Cup Base Camp